CHA AI Healthkare Completes 5 Billion Won Convertible Bond Issuance: Up to 3.15% Dilution Risk and Governance Concerns Threaten Shareholder Value
CHA AI Healthkare completed the issuance of 5 billion won in unregistered unsecured private convertible bonds with a payment date of June 19, 2026.
The initial conversion price of 12,463 won can be adjusted downward monthly via refixing to a minimum of 8,725 won, potentially converting into up to 573,296 shares or 3.15% dilution based on current outstanding shares.
Combined with existing outstanding convertible bonds of 40 billion won, total potential dilution reaches 26.97%, posing significant risk to existing shareholders.
The issuance is a private placement to ChaCares, the largest investor of the largest shareholder, raising governance concerns as all two outside directors were absent from the board resolution.
Proceeds of 5 billion won are designated for investment purposes, but no specific use has been disclosed, casting doubt on capital allocation efficiency.
No shareholder return measures such as treasury stock acquisition or cancellation were identified.
[AI Summary]CHA AI Healthkare's latest convertible bond issuance, with its related-party private placement and weak governance transparency, undermines management credibility, and combined with existing CBs totaling 27% potential dilution, severely threatens existing shareholder value.
KOSPI Filing Information
Result of Issuance of Rights Offering or Equity-Related Bonds (Voluntary Disclosure)